How much does Afinitor (Everolimus Tablets) Cost& price without insurance in China?

Afinitor® is the commercial brand name of Everolimus Tablets, an orally active mTOR inhibitor developed by Novartis. It inhibits the mammalian target of rapamycin (mTOR) signaling pathway, thereby suppressing tumor cell proliferation, angiogenesis, and metabolism.

Main Indications
Treatment of advanced renal cell carcinoma after failure of sunitinib or sorafenib therapy.
Treatment of unresectable or metastatic neuroendocrine tumors of pancreatic, gastrointestinal or lung origin.
Treatment of subependymal giant cell astrocytoma associated with tuberous sclerosis complex (TSC).
Treatment of hormone receptor-positive, HER2-negative advanced breast cancer in postmenopausal women.

Common Side Effects
Common mild adverse reactions: Stomatitis, diarrhea, fatigue, rash, and infections.
Laboratory abnormalities: Hyperlipidemia, hyperglycemia, thrombocytopenia, and neutropenia.
Severe but uncommon risks: Interstitial lung disease, severe infections, renal failure, and angioedema.

Approval Status in China
Afinitor® (Everolimus Tablets, 2.5mg) was officially approved for marketing in China in 2013. It is currently a prescription anti-tumor drug included in China’s Category B medical insurance.

Buy Afinitor (Everolimus Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.